Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:1332 (4 June), doi:10.1136/bmj.330.7503.1332
| The first 100% of the full text of this article appears below. |
EDITORGottlieb reports a study finding that consumer advertising influences doctors' prescribing.1 Recently I have had several patients attend as a result of being frightened by advertisements in the popular press. They had seen and responded to an advertisement asking if their family was infected with fungus. They had sent away for the offered literature and then attended my surgery asking for an antifungal drug by name.
Diagnosis of tinea nail infections was confirmed, and the patients wished to be treated with the stated drug despite the risk profile, expense to the NHS, and the harmlessness of the condition. Is this freedom of information and patient autonomy or scaremongering and commercial opportunism?
Graham L G McAll, general practitioner
126 Devonshire Street, Sheffield S3 7SF graham.mcall@gp-c88076.nhs.uk
Read all Rapid Responses